{{Rsnum
|rsid=1802074
|Gene=SFRP4
|Chromosome=7
|position=37907501
|Orientation=minus
|GMAF=0.2782
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SFRP4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 38.9 | 56.6
| HCB | 3.7 | 36.0 | 60.3
| JPT | 8.8 | 40.7 | 50.4
| YRI | 19.7 | 40.1 | 40.1
| ASW | 12.3 | 54.4 | 33.3
| CHB | 3.7 | 36.0 | 60.3
| CHD | 5.5 | 32.1 | 62.4
| GIH | 1.0 | 25.7 | 73.3
| LWK | 11.0 | 45.0 | 44.0
| MEX | 5.2 | 32.8 | 62.1
| MKK | 9.0 | 45.2 | 45.8
| TSI | 8.8 | 29.4 | 61.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=19562778
|Title=Wnt antagonist gene polymorphisms and renal cancer
|OA=1
}}

{{GET Evidence
|gene=SFRP4
|aa_change=Arg340Lys
|aa_change_short=R340K
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1802074
|overall_frequency_n=2625
|overall_frequency_d=10758
|overall_frequency=0.244004
|n_genomes=31
|n_genomes_annotated=0
|n_haplomes=39
|n_articles=0
|n_articles_annotated=0
|nblosum100=-3
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}